Granulocyte-monocyte Apheresis in Ulcerative Colitis
NCT03189888 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33
Last updated 2017-06-16
Summary
BACKGROUND: Granulocyte-monocyte apheresis has been proposed for the treatment of ulcerative colitis, although is limited by costs and variability of results.
Conditions
Interventions
- DEVICE
-
apheresis
Sponsors & Collaborators
-
Valduce Hospital
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
More Related Trials
-
Adacolumn in Refractory UC Patients Trial
NCT01481142 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy&Safety of ALTB-168 in Patients With Moderate to Severe Active,Anti-TNF Alpha and/or Anti-integrin Refractory UC
NCT03298022 ·Status: TERMINATED ·Phase: PHASE2
-
Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative Colitis
NCT03893565 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
NCT06588855 ·Status: RECRUITING ·Phase: PHASE3
-
Fecal Microbiota Therapy Vs 5-aminosalicylates for Induction of Remission in Newly Diagnosed Mild-moderately Active UC
NCT03716388 ·Status: UNKNOWN ·Phase: PHASE3
-
ADAPT Adacolumn Pediatric Trial in Ulcerative Colitis
NCT00781638 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis
NCT00385736 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
NCT06589986 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis
NCT04882007 ·Status: COMPLETED ·Phase: PHASE2
-
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
NCT01458951 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate a Leukapheresis Treatment in Patients With Ulcerative Colitis
NCT01097590 ·Status: COMPLETED ·Phase: PHASE1
-
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
NCT02118584 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
NCT01659138 ·Status: TERMINATED ·Phase: PHASE2
-
Study for the Treatment of Crohn's Disease With Adacolumn
NCT00162942 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis
NCT03290781 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)
NCT03006068 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis
NCT03259308 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of NP-201 Acetate Injection in Healthy Adult Volunteers and in Patients With Mild-To-Moderate Active Ulcerative Colitis
NCT06681389 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetic Study of LYC-30937 in Subjects With Active Ulcerative Colitis
NCT02818543 ·Status: COMPLETED ·Phase: PHASE1
-
Prognosis in UC After First Biological
NCT05530122 ·Status: COMPLETED
-
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
NCT00487539 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis
NCT02065622 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis
NCT03259334 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors
NCT02100696 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
NCT00488774 ·Status: TERMINATED ·Phase: PHASE2/PHASE3